
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials in indications with high unmet medical needs: AEF0117, to treat disorders...
Biotechnology,central nervous system,innovative signaling specific drugs,cb1 receptor,allosteric modulator,cannabis addiction,cognitive disorders,down syndrome,and fragil x syndrom
Aelis farma operates in the Biotechnology research industry.
Aelis farma's revenue is 1m - 10m
Aelis farma has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.